Form 8-K - Current report:
SEC Accession No. 0001193125-24-150523
Filing Date
2024-05-30
Accepted
2024-05-30 17:23:31
Documents
16
Period of Report
2024-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d723849d8k.htm   iXBRL 8-K 33361
2 EX-1.1 d723849dex11.htm EX-1.1 190484
3 EX-5.1 d723849dex51.htm EX-5.1 62649
7 GRAPHIC g723849page44a.jpg GRAPHIC 1793
  Complete submission text file 0001193125-24-150523.txt   473000

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrus-20240529.xsd EX-101.SCH 2841
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrus-20240529_lab.xml EX-101.LAB 17167
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrus-20240529_pre.xml EX-101.PRE 10782
19 EXTRACTED XBRL INSTANCE DOCUMENT d723849d8k_htm.xml XML 3568
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37773 | Film No.: 241006733
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)